CLL SLL prog list

Flow
Tutorial

Myeloproliferative neoplasms	Neoplasms with eosinophilia (PDGRA/PDGFRB/FGFR1)	MDS/MPN	MDS	AML	Acute leukemia ambiguous lineage
Precursor lymphoid neoplasms	Mature B cell neoplasms	Mature T and NK neoplasms	Hodgkin lymphoma	Immunodeficiency associated lymphoproliferative disorders	Histiocytic and dendritic cell neoplasms

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
	Unusual antigen expression abstracts	Prognostic abstracts	Cytogenetic abstracts	Antigen chart

CLL/SLL

B cell prolymphocytic leukemia

Splenic B cell marginal zone lymphoma

Hairy cell leukemia

Splenic B cell lymphoma / leukemia

Lymphoplasmacytic lymphoma

Heavy chain disease

Plasma cell neoplasms

Extranodal marginal zone lymphoma of mucosa associated lymphoid tissue

Nodal marginal zone lymphoma

Follicular lymphoma

Primary cutaneous follicle center lymhoma

Mantle cell lymphoma

Diffuse large B cell lymphoma

DLBCL associated with chronic inflammation

Lymphomatoid granulomatosis

Primary mediastinal large B cell lymphoma

Intravascular large B cell lymphoma

ALK positive large B cell lymphoma

Plasmablastic lymphoma

Large B cell lymphoma - HHV8 associated multicentric Castleman

Primary effusion lymphoma

Burkitt lymphoma

B cell lymphoma, unclassifiable with features of DLBCL and Burkitt

B cell lymphoma, unclassifiable with features of DLBCL and Hodgkin

Article	Notes
Aggressive Disease
Deletions of 11q and 17p
Genomic aberrations and survival in chronic lymphocytic leukemia.
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.
CD38 expression
CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Immunoglobulin V(H)3-21
Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.
Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study.
Deletion 6q
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis.